Starling Oncology, Inc. (STLN): Shares Outstanding
98.86M
As of 2025-12-31
100.47M
As of 2026-06-30
+10.5%
3-year compound annual growth
+76.6%
5-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 98.86M | +30.5% | 2026-03-12, Balance as of period end |
| 2024-12-31 | 75.74M | +2.1% | 2026-03-12, Balance as of period end |
| 2023-12-31 | 74.15M | +1.2% | 2025-03-26, Balance as of period end |
| 2022-12-31 | 73.27M | 0.0% | 2024-03-28, Balance as of period end |
| 2021-12-31 | 73.25M | n/m | 2023-03-16, Balance as of period end |
| 2020-12-31 | 5.75M | 0.0% | 2021-12-14, Balance as of period end |
| 2019-12-31 | 5.75M | n/a | 2021-12-14, Balance as of period end |